2018
DOI: 10.1016/j.gie.2017.10.029
|View full text |Cite
|
Sign up to set email alerts
|

Radiofrequency ablation combined with biliary stent placement versus stent placement alone for malignant biliary strictures: a systematic review and meta-analysis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

3
121
0
2

Year Published

2019
2019
2022
2022

Publication Types

Select...
3
2
2

Relationship

0
7

Authors

Journals

citations
Cited by 126 publications
(126 citation statements)
references
References 15 publications
3
121
0
2
Order By: Relevance
“…Patients who received RFA had significantly longer stent patency (50 vs 37 days, P < 0.002) and survival (285 vs 248 days, P < 0.001). The only AE that was more frequently encountered in the RFA group was abdominal pain (31% vs 20% in the control group, P = 0.003) . This survival difference was observed even though the number of patients receiving systemic chemotherapy was significantly higher in the controls compared with those treated with RFA.…”
Section: Malignant Biliary Stricturesmentioning
confidence: 87%
See 1 more Smart Citation
“…Patients who received RFA had significantly longer stent patency (50 vs 37 days, P < 0.002) and survival (285 vs 248 days, P < 0.001). The only AE that was more frequently encountered in the RFA group was abdominal pain (31% vs 20% in the control group, P = 0.003) . This survival difference was observed even though the number of patients receiving systemic chemotherapy was significantly higher in the controls compared with those treated with RFA.…”
Section: Malignant Biliary Stricturesmentioning
confidence: 87%
“…The clinical value of biliary RFA has been recently confirmed in a systematic review and meta‐analysis including nine studies including 505 patients with malignant biliary strictures in whom biliary stenting with SEMS was done with or without prior RFA application through the endoscopic or the percutaneous routes . Patients who received RFA had significantly longer stent patency (50 vs 37 days, P < 0.002) and survival (285 vs 248 days, P < 0.001).…”
Section: Malignant Biliary Stricturesmentioning
confidence: 91%
“…Endoscopic bile duct RFA therapy with a dedicated catheter has emerged as an adjunctive treatment of MBS arising from biliopancreatic malignancies . RFA therapy has already been used to treat patients with hepatocellular carcinoma or Barrett's esophagus with dysplasia.…”
Section: Discussionmentioning
confidence: 99%
“…However, definitive data from well‐controlled, prospective studies on the efficacy of endobiliary RFA are lacking. Sofi et al . published a systematic review and meta‐analysis of RFA combined with biliary stenting versus stenting alone for MBS.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation